Literature DB >> 9660179

Suppression of decorin expression and partial induction of anchorage-independent growth by the v-src oncogene in human fibroblasts.

E Kolettas1, R F Rosenberger.   

Abstract

To determine its role in cell transformations, the v-src oncogene was introduced into the human foetal diploid fibroblasts MRC-5 and into MRC-SV1, a simian virus 40 (SV40)-transformed cell line derived from them. Infected cells were found to contain stably integrated intact proviruses, as determined by Southern blot analysis. Although highly expressed, v-src did not change the morphology or growth patterns of MRC-5 cells and failed to induce foci or alter their saturation densities. However, overexpression of v-src reduced the plating efficiencies of MRC-5 and induced anchorage-independent growth in a low but significant number of cells. Northern blot analysis showed that v-src selectively abolished the expression of decorin, a small dermatan/chondroitin sulphate proteoglycan that interacts with extracellular-matrix components and modulates collagen-fibril formation and the activity of transforming growth factor (TGF) beta1. Addition of herbimycin A, a potent pp60src tyrosine-kinase inhibitor, resulted in the reexpression of decorin in MRC-5 carrying v-src. There were no changes in the expressions of fibronectin, procollagen type I, or tissue plasminogen activator, an activator of extracellular-matrix-degrading enzymes. Moreover, v-src did not alter the expressions of the epidermal-growth-factor receptor or TGFbeta1 or reduce the growth-factor requirements of MRC-5 fibroblasts. MRC-5 and MRC-SV1 expressing v-src remained non-tumourigenic when injected into nude mice. Constitutive expression of v-src did not alter the mRNA levels of c-jun and junB, suggesting that the effects of the oncogene are not mediated by AP-1. Decorin gene expression has been shown previously to be maximal in quiescent cells and virtually absent in transformed ones. Our data indicate that the ability to synthesise decorin can be suppressed in human fibroblasts without their becoming transformed, and that the relations between decorin synthesis and growth controls need further clarification.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660179     DOI: 10.1046/j.1432-1327.1998.2540266.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.

Authors:  N Yoshioka; H Inoue; K Nakanishi; K Oka; M Yutsudo; A Yamashita; A Hakura; H Nojima
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Quantification of collagen organization and extracellular matrix factors within the healing ligament.

Authors:  Connie S Chamberlain; Erin M Crowley; Hirohito Kobayashi; Kevin W Eliceiri; Ray Vanderby
Journal:  Microsc Microanal       Date:  2011-09-13       Impact factor: 4.127

Review 3.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

4.  Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.

Authors:  P Laine; N Reunanen; L Ravanti; M Foschi; M Santra; R V Iozzo; V M Kähäri
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

5.  The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.

Authors:  Alexandros Sfikas; Christina Batsi; Evangelia Tselikou; George Vartholomatos; Nikolaos Monokrousos; Periklis Pappas; Savvas Christoforidis; Theodoros Tzavaras; Panagiotis Kanavaros; Vassilis G Gorgoulis; Kenneth B Marcu; Evangelos Kolettas
Journal:  Cell Signal       Date:  2012-06-29       Impact factor: 4.315

6.  Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.

Authors:  Simone Buraschi; Thomas Neill; Rick T Owens; Leonardo A Iniguez; George Purkins; Rajanikanth Vadigepalli; Barry Evans; Liliana Schaefer; Stephen C Peiper; Zi-Xuan Wang; Renato V Iozzo
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.